NZ193239A - Anti-inflammatory compositions containing 1-(4-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid and a 2-hydroxy-5-halophenylbenzoic acid derivative - Google Patents

Anti-inflammatory compositions containing 1-(4-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid and a 2-hydroxy-5-halophenylbenzoic acid derivative

Info

Publication number
NZ193239A
NZ193239A NZ193239A NZ19323980A NZ193239A NZ 193239 A NZ193239 A NZ 193239A NZ 193239 A NZ193239 A NZ 193239A NZ 19323980 A NZ19323980 A NZ 19323980A NZ 193239 A NZ193239 A NZ 193239A
Authority
NZ
New Zealand
Prior art keywords
benzoic acid
hydroxy
phenyl
group
methoxy
Prior art date
Application number
NZ193239A
Other languages
English (en)
Inventor
T-Y Shen
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Priority to NZ197520A priority Critical patent/NZ197520A/en
Publication of NZ193239A publication Critical patent/NZ193239A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
NZ193239A 1979-03-28 1980-03-24 Anti-inflammatory compositions containing 1-(4-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid and a 2-hydroxy-5-halophenylbenzoic acid derivative NZ193239A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ197520A NZ197520A (en) 1980-03-24 1980-03-24 Analgesic/anti-inflammatory compositions based on combination of certain analgesics and 3-phenylbenzoic acid derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/024,639 US4228161A (en) 1979-03-28 1979-03-28 Anti-inflammatory combination having reduced ulcerogenicity

Publications (1)

Publication Number Publication Date
NZ193239A true NZ193239A (en) 1984-07-31

Family

ID=21821627

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ193239A NZ193239A (en) 1979-03-28 1980-03-24 Anti-inflammatory compositions containing 1-(4-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid and a 2-hydroxy-5-halophenylbenzoic acid derivative

Country Status (13)

Country Link
US (1) US4228161A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0017169B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS55130915A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR230953A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE2718T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU531174B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1124648A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3062251D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI800921A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE49652B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ193239A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT71015B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA801821B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU183408B (en) 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
WO1983001382A1 (en) * 1981-10-13 1983-04-28 Mroszczak, Edward Gastrointestinal sparing thioester pro-drugs
DE3366910D1 (en) * 1982-04-27 1986-11-20 Noristan Ltd Pharmaceutical compositions and preparation thereof
GB8607662D0 (en) * 1986-03-27 1986-04-30 Rainsford K D Pharmaceutical formulation
GB2201591B (en) * 1987-03-02 1990-11-14 Ricerfarma Srl Analgesic antipyretic and anti-inflammatory compositions.
US6767899B1 (en) * 2000-08-29 2004-07-27 Leiner Health Services Corp. Composition and method for treatment of conditions having an inflammatory component

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3161564A (en) * 1960-10-03 1964-12-15 Salsbury S Lab Dr Veterinary composition containing halo-nitro-benzamides and methods of using same
US3714226A (en) * 1970-06-09 1973-01-30 Merck & Co Inc Phenyl benzoic acid compounds
US3674870A (en) * 1970-06-09 1972-07-04 Merck & Co Inc Phenyl benzoic acid compounds in compositions and methods for treating inflammation
HU170329B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-12-12 1977-05-28
US4016268A (en) * 1975-10-06 1977-04-05 Morton-Norwich Products, Inc. Method of combatting gastric ulceration
GB1509979A (en) * 1975-11-28 1978-05-10 Fisons Ltd Pharmaceutical compositions containing aspirin or indomethacin

Also Published As

Publication number Publication date
US4228161A (en) 1980-10-14
JPS55130915A (en) 1980-10-11
PT71015A (en) 1980-04-01
PT71015B (en) 1981-06-25
AU5653780A (en) 1980-10-02
DE3062251D1 (en) 1983-04-14
AU531174B2 (en) 1983-08-11
IE800633L (en) 1980-09-28
AR230953A1 (es) 1984-08-31
IE49652B1 (en) 1985-11-13
EP0017169A1 (en) 1980-10-15
FI800921A7 (fi) 1981-01-01
JPH0153247B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-11-13
CA1124648A (en) 1982-06-01
EP0017169B1 (en) 1983-03-09
ATE2718T1 (de) 1983-03-15
ZA801821B (en) 1981-11-25

Similar Documents

Publication Publication Date Title
US4704405A (en) Rapid acting combination of sodium sulindac and a base
US5037815A (en) Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers
US5466436A (en) Medicaments for treating inflammatory conditions or for analgesia
US4766117A (en) Antiinflammatory compositions and methods
JPH0148247B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US4579846A (en) Antiinflammatory compositions and methods
US4228161A (en) Anti-inflammatory combination having reduced ulcerogenicity
US5071842A (en) Aspirin-containing composition including diphenhydramine and an alkalizing agent to reduce gastrointestinal injury potential
HU200684B (en) Process for producing pharmaceutical composition comprising comt inhibitor as active ingredient and active on gastrointestinal tract
US4256747A (en) Antiphlogistic pharmaceutical compositions and method of use
US4855293A (en) Anti-inflammatory compositions comprising a systemic non-steroidal anti-inflammatory drug and a cyclopentyl ether
US4874757A (en) Antinflammatory compositions and methods
JPH03197429A (ja) 鎮痛抗炎症剤
JPH06211662A (ja) 腸粘膜障害保護剤
JPS6388137A (ja) 非ステロイド系抗炎症剤を含む医薬製剤
EP0178122B1 (en) Improved piroxicam-containing antiinflammatory compositions
NZ197520A (en) Analgesic/anti-inflammatory compositions based on combination of certain analgesics and 3-phenylbenzoic acid derivatives
US4812455A (en) Antiinflammatory compositions and methods
US4672061A (en) Antiinflammatory compositions and methods
JP2900056B2 (ja) 非ステロイド抗炎症剤により生じる胃疾患の予防用医薬組成物
EP0017102A1 (en) Composition containing a phenyl benzoic acid compound and acetaminophen combination for the treatment of pain and inflammation and process for preparing the same
JP2586922B2 (ja) ある種のｈ▲下１▼およびｈ▲下２▼受容体遮断剤の組合せにより消化管損傷に対して保護された非ステロイド系抗炎症組成物
US4118493A (en) Method of treating hyperchlorhydria and/or associated conditions with 1,3-dioxo-1H-benz(de)isoquinoline-2-(3H)-acetic acid
JPH0395114A (ja) 胃および十二指腸の消化性潰瘍の治療薬
JPS63250322A (ja) 消化器系疾患治療剤